Publikace
- Melanoma antigens are biomarkers for ipilimumab response2017 | 3. lékařská fakulta, Ústřední knihovna
- Quantitative changes of melanoma-associated antigens as a biomarker for targeted therapy response2016 | 3. lékařská fakulta
- COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma2022 | 3. lékařská fakulta
- Pacient s progresí metastazujícího maligního melanomu do mozku během léčby nivolumabem2021 | 3. lékařská fakulta
- Targeted treatment of metastatic melanoma in a drug-addicted patient with pre-existing hepatitis C2019 | 3. lékařská fakulta
- Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors' treatment: Spectrum of imaging appearances2018 | 3. lékařská fakulta, 2. lékařská fakulta
- Killing two birds with one stone: response to pembrolizumab in a patient with metastatic melanoma and B-cell chronic lymphocytic leukaemia2018 | 3. lékařská fakulta
- Scalp melanoma after antihair loss mesotherapy2018 | 3. lékařská fakulta
- Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure2017 | 3. lékařská fakulta
- Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma2016 | 3. lékařská fakulta, 2. lékařská fakulta
Loading network view...